• About
  • Advertise
  • Careers
  • Contact Us
Tuesday, July 1, 2025
  • Login
No Result
View All Result
NEWSLETTER
Tech | Business | Economy
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
  • Chidiverse
  • News
  • Tech
    • DisruptiveTECH
    • ConsumerTech
    • How To
    • TechTAINMENT
  • Business
    • Telecoms
    • Mobility
    • Environment
    • Travel
    • StartUPs
      • Chidiverse
    • TE Insights
    • Security
  • Partners
  • Economy
    • Finance
    • Fintech
    • Digital Assets
    • Personal Finance
    • Insurance
  • Features
    • IndustryINFLUENCERS
    • Guest Writer
    • EventDIARY
    • Editorial
    • Appointment
  • TECHECONOMY TV
  • Apply
  • TBS
  • BusinesSENSE For SMEs
  • Chidiverse
No Result
View All Result
Tech | Business | Economy
No Result
View All Result
Home DisruptiveTECH

DEPLOY, a New AI Tool with 95% Accuracy for Brain Tumour Diagnosis

by Joan Aimuengheuwa
May 23, 2024
in DisruptiveTECH
0
DEPLOY, a New AI Tool with 95% Accuracy for Brain Tumor Diagnosis
Source: Neuroscience News

Source: Neuroscience News

UBA
Advertisements

A new AI tool, DEPLOY, with a commendable 95% accuracy has been developed to fight against brain tumours.

DEPLOY was built in collaboration between the Australian National University (ANU) and the National Cancer Institute (NCI) in the US.

Currently, diagnosing brain tumours often involves a lengthy wait for DNA methylation profiling, a complex and resource-intensive process that can take weeks. 

This delay can be agonizing for patients and hinder the timely initiation of treatment, especially for aggressive tumours.

“The current gold standard for identifying different kinds of brain tumours is DNA methylation-based profiling,” explains Dr Danh-Tai Hoang, a researcher at ANU. “But the time it takes to do this kind of testing can be a major drawback, often requiring several weeks or more when patients might be relying on quick decisions on therapies. There’s also a lack of availability of these tests in nearly all hospitals worldwide.”

DEPLOY tackles this challenge by leveraging deep learning, a form of artificial intelligence. It analyzes microscopic images of patient tissue samples (histopathology images) to predict the tumour subtype and infer the DNA methylation state. 

This essentially reveals which genes are active within the tumour, important information for doctors to determine the most effective treatment course.

The development of DEPLOY involved a three-pronged approach. The first model classifies brain tumour subtypes directly from the images. The second one focuses on predicting DNA methylation-based on those same images. 

Finally, the third model considers patient demographics like age and sex to further refine the tumour classification. In combining these models, DEPLOY achieves almost perfect accuracy.

Researchers precisely tested DEPLOY using data from over 4,000 patients across the US and Europe. The results were outstanding, with DEPLOY consistently achieving a 95% success rate in identifying tumour subtypes. However, the actual potential of DEPLOY goes beyond accuracy.

“Furthermore, when given a subset of 309, particularly difficult-to-classify samples, DEPLOY was able to provide a diagnosis that was more clinically relevant than what was initially provided by pathologists,” highlights Dr Hoang. 

This means that DEPLOY can act as a valuable second opinion for pathologists, potentially leading to more precise diagnoses and improved patient outcomes.

Countries with limited access to advanced diagnostic tools, like Nigeria, face a huge burden of brain tumours. The high cost of DNA methylation profiling and the lack of infrastructure often create a diagnostic bottleneck. Here, DEPLOY brings hope.

“So, there’s an urgent need to do something in the meantime, to give the oncologist some initial recommendations on what is the tumour subtype, which in turn may inform on how to tailor the treatment,” explains Dr Kenneth Aldape, Chief of the Laboratory of Pathology at NCI. 

Through the elimination of the need for expensive and time-consuming DNA methylation profiling, DEPLOY could expedite diagnoses and ensure that patients receive timely treatment.

DEPLOY’s underlying technology can be adapted to diagnose other cancers, ensuring a future where AI helps in early and accurate cancer detection. This, in turn, can lead to better treatment outcomes and a brighter future for countless patients around the world.

Loading

Advertisements
MTN ADS

Author

  • Joan Aimuengheuwa
    Joan Aimuengheuwa

    Joan thrives at helping individuals and businesses scale via storytelling...

    View all posts
0Shares
Tags: AI ToolAustralian National University (ANU)Brain TumourBrain Tumour DiagnosisDEPLOYDr Danh-Tai HoangDr Kenneth AldapeNational Cancer Institute (NCI)
Joan Aimuengheuwa

Joan Aimuengheuwa

Joan thrives at helping individuals and businesses scale via storytelling...

Next Post
FG Launches Renewed Hope Housing Delivery Portal

FG Opens Portal for Nigerians to 'Apply for Homes'

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recommended

2023 Tech in Review: Lessons Learned and Gazing at 2024

2023 Tech in Review: Lessons Learned and Gazing at 2024

2 years ago
VC Summit University at MOMAS Lagos

VC Summit University at MOMAS Lagos for Improved Town and Gown Collaboration

2 years ago

Popular News

    Connect with us

    • About
    • Advertise
    • Careers
    • Contact Us

    © 2025 TECHECONOMY.

    No Result
    View All Result
    • News
    • Tech
      • DisruptiveTECH
      • ConsumerTech
      • How To
      • TechTAINMENT
    • Business
      • Telecoms
      • Mobility
      • Environment
      • Travel
      • StartUPs
        • Chidiverse
      • TE Insights
      • Security
    • Partners
    • Economy
      • Finance
      • Fintech
      • Digital Assets
      • Personal Finance
      • Insurance
    • Features
      • IndustryINFLUENCERS
      • Guest Writer
      • EventDIARY
      • Editorial
      • Appointment
    • TECHECONOMY TV
    • Apply
    • TBS
    • BusinesSENSE For SMEs

    © 2025 TECHECONOMY.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In
    Translate »
    This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.